Key points
The following points are the key points of this manuscript:
  1. The serum levels of CXCL13 were significantly higher in SLE patients than controls.
  2. We suggested that high-avidity IgG ANAs might affect the circulation of CXCL13.
  3. The chemokine CXCL13 might be a risk factor influencing the inflammatory process in SLE.